NCT00700934

Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema

Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema. A National Registry.

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 300 (estimated)
• Sponsor: Assistance Publique - Hôpitaux de Paris · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to describe the natural history of patients with alpha-1 antitrypsin associated emphysema and to figure out associated prognostic factors.

Detailed description

All patients who suffer from this disease are followed every 6 months during a 5 years period. FEV1 decline is the primary endpoint. Quality of life assessed using the Saint George's Respiratory Questionary is recorded too.

Conditions

• Alpha 1-Antitrypsin Deficiency
• Emphysema

Timeline

• Start date: 2005-02-01
• Primary completion: 2011-02-01
• Completion: 2012-02-01
• First posted: 2008-06-19
• Last updated: 2010-12-07

Locations

1 site across 1 country: France